Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.82 USD | -0.17% | +4.09% | -42.25% |
05-14 | Editas Medicine Insider Bought Shares Worth $253,868, According to a Recent SEC Filing | MT |
05-09 | Barclays Adjusts Editas Medicine Price Target to $9 From $11, Maintains Equal Weight Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.25% | 479M | |
+69.11% | 62.86B | |
-1.24% | 41.38B | |
+45.32% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.93% | 18.9B | |
+4.25% | 12.67B | |
+25.54% | 12.27B | |
+28.69% | 12.07B |
- Stock Market
- Equities
- EDIT Stock
- News Editas Medicine, Inc.
- Transcript : Editas Medicine, Inc., Q2 2023 Earnings Call, Aug 02, 2023